VERV

Verve Therapeutics (VERV)

About Verve Therapeutics (VERV)

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Details

Daily high

$5.92

Daily low

$5.46

Price at open

$5.80

52 Week High

$13.63

52 Week Low

$4.30

Market cap

518.6M

Dividend yield

0.00%

Volume

923,050

Avg. volume

1.3M

P/E ratio

-2.49

Verve Therapeutics News